Stocks SNN Financial statements
Financial statementsSMITH & NEPHEW PLC financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SMITH & NEPHEW PLC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,669 | 4,765 | 4,904 | 5,138 | 4,560 | 5,212 | 5,215 | 5,549 | 5,810 | 6,164 |
| Cost of revenue | 1,272 | 1,248 | 1,298 | 1,338 | 1,396 | 1,543 | 1,540 | 1,730 | 1,764 | 1,972 |
| Gross profit | 3,397 | 3,517 | 3,606 | 3,800 | 3,164 | 3,669 | 3,675 | 3,819 | 4,046 | 4,192 |
| Research and development | 230 | 223 | 246 | 292 | 307 | 356 | 345 | 339 | 289 | 296 |
| Selling, general and administrative | 2,366 | 2,360 | 2,497 | 2,693 | 2,562 | 2,720 | 2,880 | 3,055 | 3,100 | 3,102 |
| General and administrative | 654 | 579 | 677 | 782 | 789 | 707 | 814 | 837 | 824 | 740 |
| Operating income | 801 | 934 | 863 | 815 | 295 | 593 | 450 | 425 | 657 | 794 |
| Interest income | 6 | 6 | 8 | 10 | 6 | 6 | 14 | 34 | 24 | 28 |
| Pre-tax income | 1,062 | 879 | 781 | 743 | 246 | 586 | 235 | 290 | 498 | 779 |
| Income tax | 278 | 112 | 118 | 143 | -202 | 62 | 12 | 27 | 86 | 154 |
| Net income | 784 | 767 | 663 | 600 | 448 | 524 | 223 | 263 | 412 | 625 |
| EBITDA | 1,216 | 1,369 | 1,290 | |||||||
| EPS, basic | 0.77 | 0.77 | 0.66 | 0.69 | 0.51 | 0.60 | 0.26 | 0.30 | 0.47 | 0.72 |
| EPS, diluted | 0.77 | 0.77 | 0.66 | 0.60 | 0.51 | 0.60 | 0.26 | 0.30 | 0.47 | 0.72 |
Balance sheet
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 38 | 155 | 333 | 257 | 1,751 | 1,285 | 350 | 302 | 619 | 557 |
| Receivables | 1,185 | 1,258 | 1,317 | 1,328 | 1,116 | 1,184 | 1,264 | 1,300 | 1,381 | 1,413 |
| Inventory | 1,244 | 1,304 | 1,395 | 1,614 | 1,691 | 1,844 | 2,205 | 2,395 | 2,387 | 2,117 |
| Total current assets | 2,529 | 2,731 | 3,077 | 3,219 | 4,664 | 4,424 | 3,856 | 4,030 | 4,421 | 4,103 |
| Property, plant and equipment | 982 | 1,049 | 1,062 | 1,323 | 1,449 | 1,513 | 1,455 | |||
| Goodwill | 2,188 | 2,371 | 2,337 | 2,789 | 2,928 | 2,989 | 3,031 | 2,992 | 3,026 | 3,108 |
| Intangible assets | 1,411 | 1,371 | 1,210 | 1,567 | 1,486 | 1,398 | 1,236 | 1,110 | 1,032 | 882 |
| Total assets | 7,344 | 7,866 | 8,059 | 9,299 | 11,012 | 10,920 | 9,966 | 9,987 | 10,354 | 10,457 |
| Accounts payable | 884 | 957 | 957 | 1,046 | 1,022 | 1,096 | 1,098 | 1,055 | 1,128 | 1,177 |
| Short-term debt | 86 | 27 | 164 | 26 | 279 | 435 | 111 | 710 | 2 | 83 |
| Total current liabilities | 1,348 | 1,346 | 1,465 | 1,564 | 1,688 | 2,131 | 1,715 | 2,271 | 1,531 | 1,595 |
| Lease liabilities | 124 | 146 | 141 | 147 | 144 | 135 | 149 | |||
| Total liabilities | 3,386 | 3,222 | 3,185 | 4,158 | 5,733 | 5,352 | 4,707 | 4,770 | 5,089 | 5,168 |
| Total debt | 1,650 | 1,450 | 1,465 | 1,877 | 3,486 | 3,142 | 2,676 | 2,885 | 3,125 | 3,111 |
| Paid-in capital | 600 | 605 | 608 | 610 | 612 | 614 | 615 | 615 | 615 | 615 |
| Retained earnings | 3,970 | 4,329 | 4,625 | 4,849 | 4,958 | 5,225 | 5,026 | 4,906 | 5,018 | 5,323 |
| Shareholders' equity | 3,958 | 4,644 | 4,874 | 5,141 | 5,279 | 5,568 | 5,259 | 5,217 | 5,265 | 5,289 |
| Total equity | 3,958 | 4,644 | 4,874 | 5,141 | 5,279 | 5,568 | 5,259 | 5,217 | 5,265 | 5,289 |
| Total liabilities and equity | 7,344 | 7,866 | 8,059 | 9,299 | 11,012 | 10,920 | 9,966 | 9,987 | 10,354 | 10,457 |
Cash flow statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 784 | 767 | 663 | 600 | 448 | 524 | 223 | 263 | 412 | 625 |
| Depreciation and amortization | 415 | 435 | 427 | |||||||
| Cash from operations | 849 | 1,090 | 931 | 1,168 | 935 | 877 | 468 | 608 | 987 | 1,285 |
| Cash from investing | -383 | -543 | -378 | -1,251 | -606 | -691 | -472 | -448 | -569 | -406 |
| Debt issued | 924 | 623 | 394 | 1,290 | 950 | 326 | 43 | |||
| Share buybacks | -368 | -52 | -48 | -63 | -16 | -158 | -502 | |||
| Dividends paid | -279 | -269 | -321 | -318 | -328 | -329 | -327 | -327 | -327 | -330 |
| Cash from financing | -529 | -434 | -371 | 7 | 1,164 | -645 | -926 | -200 | -86 | -955 |
| Exchange rate effect | -1 | 4 | -4 | 1 | -7 | -11 | -4 | -15 | 12 | |
| Interest paid | 48 | 50 | 54 | 56 | 61 | 80 | 73 | 104 | 140 | 142 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 68.0% | Gross profit / revenue. |
| Operating margin | 12.9% | Operating income / revenue. |
| Pre-tax margin | 12.6% | Pre-tax income / revenue. |
| Net margin | 10.1% | Net income / revenue. |
| Operating cash flow margin | 20.8% | Cash from operations / revenue. |
| Effective tax rate | 19.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 11.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 6.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 8.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 4.8% | Research and development expense / revenue. |
| SG&A / revenue | 50.3% | Selling, general and administrative expense / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 6.1% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 5.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 6.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 3.6% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 4.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 5.8% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 20.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 20.8% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 21.9% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 51.7% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 41.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 6.9% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 52.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 41.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 6.9% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 30.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 40.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 6.6% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 0.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 0.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 0.0% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 1.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 1.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -1.0% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.57x | Current assets / current liabilities. |
| Quick ratio | 1.24x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.35x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.59x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 29.8% | Total debt / total assets. |
| Liabilities / assets | 49.4% | Total liabilities / total assets. |
| Net debt | $2.55B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Working capital | $2.51B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 38.2% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $1.30B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.59x | Revenue / average total assets. |
| Inventory turnover | 0.88x | Cost of revenue / average inventory. |
| Days inventory | 417 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 4.41x | Revenue / average receivables. |
| Days sales outstanding | 83 days | 365 x average receivables / revenue. |
| Days payables | 213 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 286 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.72 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.72 | Net income per basic share, as reported (split-adjusted). |
| Payout ratio | 52.8% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $11.51B | Share price x shares outstanding. |
| Enterprise value | $14.06B | Market cap + total debt - cash - short-term investments. |
| P/E | 18.4x | Market cap / net income. Only when net income is positive. |
| P/S | 1.87x | Market cap / revenue. |
| P/B | 2.18x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 8.86x | Market cap / tangible book value, when positive. |
| P/OCF | 8.95x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.28x | Enterprise value / revenue. |
| EV/EBIT | 17.7x | Enterprise value / operating income, when both are positive. |
| Earnings yield | 5.4% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 2.9% | Dividends paid over the period / market cap. |
| Shareholder yield | 7.2% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.45x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was SMITH & NEPHEW PLC's revenue in fiscal 2025?
SMITH & NEPHEW PLC reported revenue of $6.16B for fiscal 2025, 6.1% higher than the year before.
Was SMITH & NEPHEW PLC profitable in fiscal 2025?
Yes. Net income was $625.0M, a net margin of 10.1%.